Arrowhead Receives Orphan Drug Designation for ARC-AAT
Go back to Arrowhead Receives Orphan Drug Designation for ARC-AAT| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 85.25 -0.12 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.37 | 52 Week High | $8.22 | |||
| Open | $85.18 | 52 Week Low | $3.07 | |||
| Day High | $85.71 | P/E | N/A | |||
| Day Low | $83.46 | EPS | $-1.30 | |||
| Volume | 689,973 | |||||
